University of Maryland School of Medicine Expert Co-Led Novavax Trial That Led to FDA Emergency Use Authorization and CDC Recommendation
July 26, 2022
July 26, 2022
BALTIMORE, Maryland, July 26 (TNSjou) -- The University of Maryland School of Medicine issued the following news:
* * *
Protein-based vaccine offers new option for primary vaccination of unvaccinated adults
* * *
The Centers for Disease Control and Prevention (CDC) this week recommended a new COVID-19 protein-based vaccine as an option for primary vaccination of adults 18 years of age and older. The University of Maryland School of Medicine . . .
* * *
Protein-based vaccine offers new option for primary vaccination of unvaccinated adults
* * *
The Centers for Disease Control and Prevention (CDC) this week recommended a new COVID-19 protein-based vaccine as an option for primary vaccination of adults 18 years of age and older. The University of Maryland School of Medicine . . .